Jodix

Potassium Iodide, the active ingredient in Jodix, is an iodide class drug presented as an oral tablet for oral use. It is employed to block thyroid uptake of radioactive iodine and to prevent iodine deficiency in populations at risk. The compound provides stable iodine that saturates the thyroid gland, thereby reducing the organ’s ability to absorb harmful radioactive isotopes during nuclear incidents.

GNH USA supplies Jodix as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and research institutions worldwide.

Jodix, a potassium iodide preparation, is used in situations that involve thyroid iodine uptake. - Radiation exposure prophylaxis: Reduces thyroid absorption of radioactive iodine following nuclear incidents. - Thyroid protection during nuclear emergencies: Provides stable iodine to saturate the gland and limit radiation‑induced thyroid damage. - Prevention of iodine deficiency: Supplies essential iodine to populations lacking adequate dietary iodine.

Potassium iodide may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Nausea: mild stomach upset that may appear within an hour of ingestion. - Vomiting: occasional expulsion of stomach contents, generally self‑limiting. - Metallic taste: transient metallic sensation in the mouth lasting a few minutes. - Abdominal pain: cramping or discomfort in the abdomen that resolves without treatment. - Diarrhea: loose stools occurring shortly after dosing, usually brief.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or anaphylaxis requiring immediate medical care. - Thyrotoxicosis: excessive thyroid hormone release in susceptible individuals, causing palpitations and heat intolerance. - Hypothyroidism: reduced thyroid function after prolonged use, presenting with fatigue and weight gain. - Hyperkalemia: elevated blood potassium levels, especially in renal impairment, which may affect heart rhythm.

When using potassium iodide, several precautions should be observed to ensure safety and effectiveness. - Assess iodine status: verify that the individual has not received recent iodine supplementation. - Evaluate thyroid health: consider existing thyroid disorders before administration. - Monitor renal function: patients with kidney disease may be at risk of hyperkalemia. - Avoid in known hypersensitivity: discontinue if allergic reactions develop. - Limit duration: use only for the recommended period during radiation exposure events. - Store at ambient temperature: keep below 25°C in the original container, protected from moisture.

Potassium iodide can interact with certain medicines, affecting either its efficacy or safety.

Major Interactions (Avoid): - Lithium: concurrent use may increase lithium toxicity due to altered renal excretion. - Antithyroid drugs (e.g., propylthiouracil, methimazole): may reduce the intended thyroid‑blocking effect. - ACE inhibitors or ARBs: risk of hyperkalemia may be heightened when combined.

Moderate Interactions (Monitor Closely): - Diuretics that spare potassium (e.g., spironolactone): monitor serum potassium levels. - Radioactive iodine therapy: timing must be coordinated to avoid interference with diagnostic scans. - Thyroid hormone replacement (levothyroxine): dosage may need adjustment after potassium iodide administration. - Beta‑blockers: may mask symptoms of thyrotoxicosis, requiring careful clinical observation.